Skip to main content

Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren)

Searching for OpenAIRE data...

Publications

FAILURE OF BIOMARKERS TO PERSONALIZE CLINICAL PRACTISE IN DIABETIC KIDNEY DISEASE ARE WE ASKING THE RIGHT QUESTIONS?

Author(s): Sara Denicolò, Felix Keller, Stefanie Thöni, Gert Mayer und Bernd Mayer* Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck *emergentec biodevelopment GmbH, Vienna
Published in: Nephro-News, Issue 02/2020, 2020, Page(s) 17-21, ISSN 1682-6817